M1 MedTech Accelerator Program 2022 for Early-stage Medical Device Founders

Are you ready to bring the next major medical innovation to market? Apply for the M1 MedTech Accelerator Program 2022 right now.

M1 MedTech Accelerator Program

M1 is a medical technology accelerator that helps early-stage medical device innovators move quickly toward commercialization.

They bring together a diverse network of founders, advisers, service providers, and subject matter experts to mentor cohort teams during and beyond the program. Teams get an equity investment and engage in a three-month hands-on, practical workshop program intended to accelerate business and product development in weeks rather than years.



M1 begins by investing in each cohort firm with an initial equity investment. Then, each cohort goes through a practical, hands-on 12-week workshop program conducted by verified subject matter experts, covering subjects such as firm creation and management, intellectual property, design and quality controls, preclinical and clinical testing, and regulatory approval.


Each team selected for the program is also mentored and coached on an ongoing basis by the M1 team and its partners.


Finally, M1 provides in-person networking and presenting opportunities, such as program kickoffs, investor dinners, and preliminary and final pitch events.

M1 MedTech Accelerator Program | Eligibility Criteria

  • Open to early-stage medical device entrepreneurs;
  • The applicant must be available to take part in all components of the program.

M1 MedTech Accelerator Program | Application Procedure

M1 will use the application to learn more about your team, product, stage of development, and important milestones, and to determine whether you are a suitable match for their program.

They are now taking applications for the Fall 2022 program cycle, which starts in mid-August. These applications must be submitted by May 31, and judgments must be made by July 15.

To apply, please click here.

Deadline: May 31, 2022

M1 MedTech Accelerator has further information.

Recommended for You

Add a Comment

Your email address will not be published.